FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283457352> ?p ?o ?g. }

• W4283457352 abstract "Spinal and bulbar muscular atrophy (SBMA), also known as Kennedy's disease, is a rare, slowly progressive, incurable, and hereditary neurodegenerative disease caused by the testosterone-dependent accumulation of pathogenic polyglutamine-expanded androgen receptor protein. After extensive review, two treatments for SBMA have recently been approved in Japan; this decision was based on the results of randomized controlled trials: First, anti-androgen therapy using leuprorelin acetate (leuprorelin), a disease-modifying drug that can inhibit the progression of dysphagia but has not yet been proved to improve gait function; second, cybernic treatment with a wearable cyborg hybrid assistive limb (HAL®) (Cyberdyne Inc. Tsukuba, Japan). The HAL is an innovative walking exercise system that has been shown to significantly improve gait function in eight neuromuscular diseases without reduction in muscle function, including SBMA. It is possible that the combination of these two approaches might yield better outcomes. However, the long-term effects of such a combined approach have yet to be clinically evaluated. Here, we describe the case of a 39-year-old male with SBMA who commenced anti-androgen therapy with leuprorelin 1 year previously; this was followed by cybernic treatment with HAL. The duration of walking exercise with HAL was 20-30 min a day in one session. Over 2 weeks, the patient underwent nine sessions (one course). The efficacy of HAL was evaluated by gait function tests before and after one course of cybernic treatment. Then, leuprorelin treatment was combined with cybernic sessions every 2 months for 2 years (13 courses in total). Walking ability, as evaluated by the 2-min walk test, improved by 20.3% in the first course and peaked 10 months after the commencement of combined therapy (a 59.0% improvement). Walking function was maintained throughout the period. Generally, SBMA is characterized by moderately increased serum levels of creatine kinase (CK), reflecting neuromuscular damage; interestingly, the patient's CK levels decreased dramatically with combined therapy, indicating remarkable functional improvement. Long-term combined therapy improved the patient's gait function with a steady reduction in CK levels. The combination of leuprorelin with cybernic treatment can, therefore, improve and maintain gait function without damaging the motor unit and may also suppress disease progression." @default.
• W4283457352 created "2022-06-26" @default.
• W4283457352 creator A5036681718 @default.
• W4283457352 creator A5045535997 @default.
• W4283457352 creator A5055620250 @default.
• W4283457352 creator A5056748506 @default.
• W4283457352 creator A5060933834 @default.
• W4283457352 creator A5076778395 @default.
• W4283457352 date "2022-06-24" @default.
• W4283457352 modified "2023-10-14" @default.
• W4283457352 title "The Combined Efficacy of a Two-Year Period of Cybernic Treatment With a Wearable Cyborg Hybrid-Assistive Limb and Leuprorelin Therapy in a Patient With Spinal and Bulbar Muscular Atrophy: A Case Report" @default.
• W4283457352 cites W1564910331 @default.
• W4283457352 cites W1571600557 @default.
• W4283457352 cites W1985902870 @default.
• W4283457352 cites W2003223441 @default.
• W4283457352 cites W2003935058 @default.
• W4283457352 cites W2003966010 @default.
• W4283457352 cites W2013452556 @default.
• W4283457352 cites W2022527711 @default.
• W4283457352 cites W2074342599 @default.
• W4283457352 cites W2084694065 @default.
• W4283457352 cites W2108834942 @default.
• W4283457352 cites W2113333419 @default.
• W4283457352 cites W2140530485 @default.
• W4283457352 cites W2155478811 @default.
• W4283457352 cites W2159317313 @default.
• W4283457352 cites W2231489206 @default.
• W4283457352 cites W2742460030 @default.
• W4283457352 cites W2775386989 @default.
• W4283457352 cites W2789114047 @default.
• W4283457352 cites W2790886139 @default.
• W4283457352 cites W2897459153 @default.
• W4283457352 cites W2922439241 @default.
• W4283457352 cites W2938333060 @default.
• W4283457352 cites W2983695480 @default.
• W4283457352 cites W3176472284 @default.
• W4283457352 cites W3182639744 @default.
• W4283457352 cites W4213250783 @default.
• W4283457352 cites W4242614327 @default.
• W4283457352 doi "https://doi.org/10.3389/fneur.2022.905613" @default.
• W4283457352 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35812096" @default.
• W4283457352 hasPublicationYear "2022" @default.
• W4283457352 type Work @default.
• W4283457352 citedByCount "1" @default.
• W4283457352 countsByYear W42834573522023 @default.
• W4283457352 crossrefType "journal-article" @default.
• W4283457352 hasAuthorship W4283457352A5036681718 @default.
• W4283457352 hasAuthorship W4283457352A5045535997 @default.
• W4283457352 hasAuthorship W4283457352A5055620250 @default.
• W4283457352 hasAuthorship W4283457352A5056748506 @default.
• W4283457352 hasAuthorship W4283457352A5060933834 @default.
• W4283457352 hasAuthorship W4283457352A5076778395 @default.
• W4283457352 hasBestOaLocation W42834573521 @default.
• W4283457352 hasConcept C121608353 @default.
• W4283457352 hasConcept C126322002 @default.
• W4283457352 hasConcept C168563851 @default.
• W4283457352 hasConcept C1862650 @default.
• W4283457352 hasConcept C2778575703 @default.
• W4283457352 hasConcept C2778894405 @default.
• W4283457352 hasConcept C2779093440 @default.
• W4283457352 hasConcept C2780192828 @default.
• W4283457352 hasConcept C2780434838 @default.
• W4283457352 hasConcept C61367390 @default.
• W4283457352 hasConcept C71315377 @default.
• W4283457352 hasConcept C71924100 @default.
• W4283457352 hasConcept C99508421 @default.
• W4283457352 hasConceptScore W4283457352C121608353 @default.
• W4283457352 hasConceptScore W4283457352C126322002 @default.
• W4283457352 hasConceptScore W4283457352C168563851 @default.
• W4283457352 hasConceptScore W4283457352C1862650 @default.
• W4283457352 hasConceptScore W4283457352C2778575703 @default.
• W4283457352 hasConceptScore W4283457352C2778894405 @default.
• W4283457352 hasConceptScore W4283457352C2779093440 @default.
• W4283457352 hasConceptScore W4283457352C2780192828 @default.
• W4283457352 hasConceptScore W4283457352C2780434838 @default.
• W4283457352 hasConceptScore W4283457352C61367390 @default.
• W4283457352 hasConceptScore W4283457352C71315377 @default.
• W4283457352 hasConceptScore W4283457352C71924100 @default.
• W4283457352 hasConceptScore W4283457352C99508421 @default.
• W4283457352 hasFunder F4320321945 @default.
• W4283457352 hasLocation W42834573521 @default.
• W4283457352 hasLocation W42834573522 @default.
• W4283457352 hasLocation W42834573523 @default.
• W4283457352 hasOpenAccess W4283457352 @default.
• W4283457352 hasPrimaryLocation W42834573521 @default.
• W4283457352 hasRelatedWork W152616065 @default.
• W4283457352 hasRelatedWork W1970491283 @default.
• W4283457352 hasRelatedWork W1974477415 @default.
• W4283457352 hasRelatedWork W2007234093 @default.
• W4283457352 hasRelatedWork W2113722195 @default.
• W4283457352 hasRelatedWork W2123231783 @default.
• W4283457352 hasRelatedWork W2159317313 @default.
• W4283457352 hasRelatedWork W2416259612 @default.
• W4283457352 hasRelatedWork W2464868658 @default.
• W4283457352 hasRelatedWork W1849765557 @default.
• W4283457352 hasVolume "13" @default.
• W4283457352 isParatext "false" @default.
• W4283457352 isRetracted "false" @default.
• W4283457352 workType "article" @default.